|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 9/16 | (2006.01) |
| A61K 9/48 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 1/00 | (2006.01) | ||
| A61K 31/496 | (2006.01) |
| (11) | Patento numeris | 4178548 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 21755119.1 |
| Europos patento paraiškos padavimo data | 2021-07-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2023-05-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-07-24 |
| (46) | Apibrėžties vertimo paskelbimo data | 2024-09-25 |
| (86) | Numeris | PCT/US2021/040452 |
| Data | 2021-07-06 |
| (87) | Numeris | WO 2022/010854 |
| Data | 2022-01-13 |
| (30) | Numeris | Data | Šalis |
| 202063048998 P | 2020-07-07 | US |
| (72) |
AGRAWAL, Anjali , US
MITRA, Biplob, K. , US
THOOL, Prajwal, Gunwanth , US
HIGGINS-GRUBER, Shannon , US
RODRIGUEZ, Jennifer, Almodovar , US
LIU, Demin , US
|
| (73) |
Celgene Corporation ,
Route 206 & Province Line Road, Princeton, NJ 08543,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Farmacinė kompozicija, apimanti (S)-4-(4-(4-(((2-(2,6-dioksopiperidin-3-il) -1-oksoizoindolin-4-il)oksi)metil)benzil)piperazin-1-il)-3-fluorbenzonitrilą, ir jos panaudojimo būdai |
| PHARMACEUTICAL COMPOSITIONS COMPRISING (S)-4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)METHYL) BENZYL)PIPERAZIN-1-YL)-3-FLUOROBENZONITRILE AND METHODS OF USING THE SAME |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-06-04 | 5 | 115.00 EUR |
| 2026-07-06 |